Nongenomic effects of an anti-idiotypic antibody as an estrogen mimetic in female human and rat osteoblasts

Keyphrases

• Estrogen 100%
• Non-genomic Effects 100%
• Anti-idiotypic Antibody 100%
• Human Osteoblasts 100%
• Rat Osteoblasts 100%
• Creatine Kinase 75%
• Ca2+ 75%
• Membrane Effect 75%
• Specific Activity 50%
• Ca2+ Response 50%
• Genomic Effects 50%
• Calcium Concentration 25%
• Cytosolic Calcium 25%
• 17-estradiol 25%
• High Concentration 25%
• Binding Site 25%
• Ca2+ Influx 25%
• Ca2+ Mobilization 25%
• Testosterone 25%
• Endoplasmic Reticulum 25%
• Nifedipine 25%
• Gender-specific 25%
• Estrogen Receptor 25%
• Nuclear Receptor 25%
• Pertussis Toxin-sensitive G Proteins 25%
• Channel Blocker 25%
• Membrane Binding 25%
• Phospholipase C 25%
• Antibody Clones 25%
• Early Effect 25%
• Neomycin 25%
• Chelator 25%
• Voltage-gated Ca2+ Channels 25%
• Proteolytic Fragments 25%
• Raloxifene 25%
• Estrogenic Activity 25%
• Extracellular Ca2+ 25%
• U73122 25%

Biochemistry, Genetics and Molecular Biology

• Osteoblast 100%
• Creatine Kinase 75%
• Genomics 50%
• Binding Site 25%
• Calcium Channel 25%
• Membrane Binding 25%
• Pertussis Toxin 25%
• Estrogen Receptor 25%
• Neomycin 25%
• Nuclear Receptor 25%
• Voltage-Gated Calcium Channels 25%
• Estradiol 25%
• Nifedipine 25%
• G Protein 25%
• Lecithinase 25%
• Raloxifene 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Calcium Ion 100%
• Antiidiotypic Antibody 100%
• Creatine Kinase 42%
• Calcium Channel 28%
• Dimer 14%
• Diethylstilbestrol 14%
• Nifedipine 14%
• Binding Site 14%
• Pertussis Toxin 14%
• Guanine Nucleotide Binding Protein 14%
• Channel Blocker 14%
• Egtazic Acid 14%
• Chelating Agent 14%
• Neomycin 14%
• Estrogen Receptor 14%
• Cell Nucleus Receptor 14%
• Raloxifene 14%
• Tamoxifen 14%
• Nuclear Estrogen 14%
• Phospholipase C Inhibitor 14%